$Lack of antibodies to NMDAR or VGKC-complex in GAD and cardiolipin antibody-positive refractory epilepsy.$

Lack of antibodies to NMDAR or VGKC-complex in GAD and cardiolipin antibody-positive refractory epilepsy.

BACKGROUND: Over the last few years autoantibodies against neuronal proteins have been identified in several forms of autoimmune encephalitis and epilepsy. NMDA receptor (NMDAR) and voltage gated potassium channel (VGKC) complex antibodies are mainly associated with limbic encephalitis (LE) whereas...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Liimatainen, S, Peltola, J, Hietaharju, A, Sabater, L, Lang, B
Natura:	Journal article
Lingua:	English
Pubblicazione:	2014

Documenti analoghi

ANTI-GAD65, NMDAR AND VGKC ANTIBODIES DETECTED IN FIRST EPISODE PSYCHOSIS
di: Lennox, B, et al.
Pubblicazione: (2009)

Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies.
di: Pellkofer, H, et al.
Pubblicazione: (2010)

VGKC-complex antibody encephalitis.
di: Willis, MD, et al.
Pubblicazione: (2014)

GAD antibodies in stiff-person syndrome.
di: Chang, T, et al.
Pubblicazione: (2004)

Elevated VGKC-complex antibodies in a boy with fever-induced refractory epileptic encephalopathy in school-age children (FIRES).
di: Illingworth, M, et al.
Pubblicazione: (2011)

Detection of NMDARs antibodies in encephalitis
di: Gastaldi, M, et al.
Pubblicazione: (2017)

VGKC antibodies in pediatric encephalitis presenting with status epilepticus.
di: Suleiman, J, et al.
Pubblicazione: (2011)

Hypothermia in VGKC antibody-associated limbic encephalitis.
di: Jacob, S, et al.
Pubblicazione: (2008)

Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity.
di: Malter, M, et al.
Pubblicazione: (2014)

NMDAR-antibody encephalitis: psychopathology and immunobiology
di: Al-Diwani, A
Pubblicazione: (2020)

GAD antibodies in neurological disease: a critical evaluation of the utility and treatment implications of GAD antibodies in clinical practice
di: Brown, RL, et al.
Pubblicazione: (2025)

Clinical relevance of specific IgG antibodies of cardiolipin.
di: Faux, J, et al.
Pubblicazione: (1989)

Stiff, twitchy or wobbly - Are GAD antibodies pathogenic?
di: Vincent, A
Pubblicazione: (2008)

Stiff, twitchy or wobbly: are GAD antibodies pathogenic?
di: Vincent, A
Pubblicazione: (2008)

Gerstmann-Straussler-Scheinker disease: novel PRNP mutation and VGKC-complex antibodies.
di: Jones, M, et al.
Pubblicazione: (2014)

Immune-mediated steroid-responsive epileptic spasms and epileptic encephalopathy associated with VGKC-complex antibodies.
di: Suleiman, J, et al.
Pubblicazione: (2011)

A comparison of NMDAR-antibody detection methods
di: Thouin, A, et al.
Pubblicazione: (2017)

Comparison of antibody assays in anti-NMDAR encephalitis
di: Gastaldi, M, et al.
Pubblicazione: (2016)

Ongoing germinal centre reactions contribute to N-methyl-D-aspartate receptor (NMDAR) antibody production in nmdar-antibody encephalitis
di: Makuch, M, et al.
Pubblicazione: (2018)

SERUM ANTIBODIES IN EPILEPSY
di: Brenner, T, et al.
Pubblicazione: (2009)

Suspected limbic encephalitis and seizure in cats associated with voltage-gated potassium channel (VGKC) complex antibody.
di: Pakozdy, A, et al.
Pubblicazione: (2013)

SERUM ANTIBODIES IN EPILEPSY
di: Brenner, T, et al.
Pubblicazione: (2009)

Characterisation of anti-GAD antibodies in stiff-person syndrome
di: Chang, T, et al.
Pubblicazione: (2006)

EEG-confirmed epileptic activity in a cat with VGKC-complex/LGI1 antibody-associated limbic encephalitis.
di: Pakozdy, A, et al.
Pubblicazione: (2014)

Immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal loss
di: Chang, T, et al.
Pubblicazione: (2013)

Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre.
di: Paterson, R, et al.
Pubblicazione: (2014)

Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: Experience from a tertiary referral centre
di: Paterson, R, et al.
Pubblicazione: (2014)

Vgkc is dead: long live lgi1- and caspr2-antibodies. intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
di: Lang, B, et al.
Pubblicazione: (2017)

Serum antibodies in patients with epilepsy
di: Lang, B, et al.
Pubblicazione: (2005)

The movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study
di: Varley, J, et al.
Pubblicazione: (2018)

Relative frequency of VGKC and 'classical' paraneoplastic antibodies in patients with limbic encephalitis.
di: Jarius, S, et al.
Pubblicazione: (2008)

EPILEPSY AND THE IMMUNE SYSTEM " ... IS THERE ANTIBODY THERE? ... ''
di: Wright, S, et al.
Pubblicazione: (2012)

NMDAR antibodies; cognitive and behavioural abnormalities in mice injected with patient IgG
di: Philippa, P, et al.
Pubblicazione: (2010)

The movement disorder associated with NMDAR-antibody encephalitis: an expert-rater video study
di: Varley, JA, et al.
Pubblicazione: (2016)

VGKC-complex antibody mediated encephalitis presenting with psychiatric features and neuroleptic malignant syndrome - further expanding the phenotype.
di: Iyer, A, et al.
Pubblicazione: (2012)

Investigating the pathogenic effects of antibodies against the VGKC-complex and N-methyl-D-aspartate receptor in CNS disorders
di: Pettingill, PM
Pubblicazione: (2013)

The clinical phenotype of non-paraneoplastic voltage gated potassium channel antibody (VGKC Ab) associated CNS disease
di: Seymour, A, et al.
Pubblicazione: (2004)

Serum antibodies in epilepsy and seizure-associated disorders.
di: McKnight, K, et al.
Pubblicazione: (2005)

Antibodies to voltage-gated potassium and calcium channels in epilepsy.
di: Majoie, H, et al.
Pubblicazione: (2006)

GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes.
di: Castleden, H, et al.
Pubblicazione: (2006)